3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Breast Neoplasms
7
Fatigue
3
Pain
2
Vomiting
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neurotoxicity Syndromes
1
Neoplasms
1
Multiple Myeloma
1
Mucositis
1
Lung Neoplasms
1
Leukemia
1
Ileus
1
Hot Flashes
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
Female Breast Cancer
1
Depression
1
Bronchiolitis Obliterans Syndrome
1
Breast Neoplasms, Male
1
Interventions
Cisplatin
4
Radiotherapy, Intensity-Modulated
3
Radiotherapy
3
pembrolizumab
2
Cetuximab
2
Biopsy
2
utomilumab
1
tremelimumab
1
motexafin gadolinium
1
durvalumab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Radiosurgery
1
Radiation
1
Platinum
1
Observation
1
Nivolumab
1
Ipilimumab
1
Immunohistochemistry
1
Immunoglobulin G
1
Fluorouracil
1
Fluorescent Antibody Technique
1
Flow Cytometry
1
Etoposide
1
Electroacupuncture
1
Drug Therapy
1
Disulfides
1
Diagnosis, Oral
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Oropharyngeal Neoplasms
×
Acupuncture Therapy
×
Clear all
NCT01883908
2019-11-07
GCC1229
University of Maryland, Baltimore
Phase NA
Terminated
4 enrolled
3 charts